Michael Reaves/Getty Images
The San Francisco Giants were involved in the most shocking offseason turn of events this week when they held up their deal with star shortstop Carlos Correa over a medical concern, opening the door for him to sign with the New York Mets.
On Thursday, ESPN’s Jeff Passan shed light on the thought process behind San Francisco’s hesitation, revealing the team had concerns about Correa’s lower right leg following his physical examination. The 28-year-old had broken his fibula in 2014 on a slide during a minor league game which led to surgery.
Passan noted that the Giants’ fear “concerned the long-term stability of his leg—and the potential for Correa to quickly lose the mobility that won him a Platinum Glove in 2021.”
The assertion likely came as a shock to Correa, who had agreed to a 13-year, $350 million deal on Dec 13. Per Passan, his surgically repaired leg was an injury he “hadn’t thought about in years, and suddenly it was putting in jeopardy the fourth-largest guaranteed contract in North American sports history.”
Correa’s agent, Scott Boras, dismissed the notion that an injury from eight years ago could affect his client down the line, pointing out that Correa received a 10-year contract offer from the Minnesota Twins, with whom he played the 2022 season.
“If a team familiar with his medical history was willing to offer Correa a decade-long contract, [Boras’] reasoning went, how bad could the injury really be?” Passan wrote.
The Mets swooped in and signed Correa to a 12-year, $315 million contract. It was another heartbreaker for San Francisco this offseason after its failed pursuit of American League MVP Aaron Judge, who re-signed with the New York Yankees.
The Giants are hoping to bounce back from a disappointing 2022 season in which they finished with an 81-81 record and failed to make the playoffs for the fifth time in the last six years.